These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 22507770)

  • 1. Bone marrow failure and the new telomere diseases: practice and research.
    Young NS
    Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskeratosis congenita, stem cells and telomeres.
    Kirwan M; Dokal I
    Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow failure and the telomeropathies.
    Townsley DM; Dumitriu B; Young NS
    Blood; 2014 Oct; 124(18):2775-83. PubMed ID: 25237198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes.
    Arias-Salgado EG; Galvez E; Planas-Cerezales L; Pintado-Berninches L; Vallespin E; Martinez P; Carrillo J; Iarriccio L; Ruiz-Llobet A; Catalá A; Badell-Serra I; Gonzalez-Granado LI; Martín-Nalda A; Martínez-Gallo M; Galera-Miñarro A; Rodríguez-Vigil C; Bastos-Oreiro M; Perez de Nanclares G; Leiro-Fernández V; Uria ML; Diaz-Heredia C; Valenzuela C; Martín S; López-Muñiz B; Lapunzina P; Sevilla J; Molina-Molina M; Perona R; Sastre L
    Orphanet J Rare Dis; 2019 Apr; 14(1):82. PubMed ID: 30995915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
    Agarwal S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere shortening in human diseases.
    Kong CM; Lee XW; Wang X
    FEBS J; 2013 Jul; 280(14):3180-93. PubMed ID: 23647631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
    Du HY; Pumbo E; Ivanovich J; An P; Maziarz RT; Reiss UM; Chirnomas D; Shimamura A; Vlachos A; Lipton JM; Goyal RK; Goldman F; Wilson DB; Mason PJ; Bessler M
    Blood; 2009 Jan; 113(2):309-16. PubMed ID: 18931339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abnormality of telomere maintenance linked to bone marrow failures].
    Yamaguchi H
    Nihon Rinsho; 2008 Mar; 66(3):483-9. PubMed ID: 18326318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
    Gramatges MM; Bertuch AA
    Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in dyskeratosis congenita.
    Nishio N; Kojima S
    Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human telomere disease due to disruption of the CCAAT box of the TERC promoter.
    Aalbers AM; Kajigaya S; van den Heuvel-Eibrink MM; van der Velden VH; Calado RT; Young NS
    Blood; 2012 Mar; 119(13):3060-3. PubMed ID: 22323451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
    Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
    Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of TERC haploinsufficiency on the inheritance of telomere length.
    Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
    Hoffman H; Rice C; Skordalakes E
    J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere maintenance and human bone marrow failure.
    Calado RT; Young NS
    Blood; 2008 May; 111(9):4446-55. PubMed ID: 18239083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of telomere biology disorders.
    Grill S; Nandakumar J
    J Biol Chem; 2021; 296():100064. PubMed ID: 33482595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
    Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
    Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.